European Commission 24 April 2015, Commission Delegated Regulation (EU) 2015/1011 of 24 April 2015 supplementing Regulation (EC) No 273/2004 of the European Parliament and of the Council on drug precursors and Council Regulation (EC) No 111/2005 laying down rules for the monitoring of trade between the Union and third countries in drug precursors, and repealing Commission Regulation (EC) No 1277/2005 (Text with EEA relevance)

Also known as

European Union · · · Cited by 48 · 27-06-2015

Article 1. Subject matter
Article 2. Definitions
Article 3. Conditions for granting licences
Article 4. Cases where a licence is not required
Article 5. Conditions for granting registrations
Article 6. Cases where a registration is not required
Article 7. Conditions for exemptions from certain requirements
Article 8. Criteria for determining the licit purposes of a transaction
Article 9. Information required to monitor trade
Article 10. Conditions for determining the lists of the countries of destination for exports of scheduled substances of Categories 2 and 3
Article 11. Criteria for determining simplified procedures for pre-export notifications
Article 12. Criteria for determining simplified procedures for export authorisations
Article 13. Conditions and requirements concerning the information to be provided on the implementation of the monitoring measures
Article 14. Repeal
Article 15.
ANNEX I. ANNEX II

27.6.2015

Official Journal of the European Union

L 162/12

COMMISSION DELEGATED REGULATION (EU) 2015/1011

of 24 April 2015

supplementing Regulation (EC) No 273/2004 of the European Parliament and of the Council on drug precursors and Council Regulation (EC) No 111/2005 laying down rules for the monitoring of trade between the Union and third countries in drug precursors,

Read the full text

This document is published by eur-lex.europa.eu.

Moonlit adds the citation network (48 references), article-level links and cross-references, which are available to search for free.